JP2008520669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520669A5 JP2008520669A5 JP2007543135A JP2007543135A JP2008520669A5 JP 2008520669 A5 JP2008520669 A5 JP 2008520669A5 JP 2007543135 A JP2007543135 A JP 2007543135A JP 2007543135 A JP2007543135 A JP 2007543135A JP 2008520669 A5 JP2008520669 A5 JP 2008520669A5
- Authority
- JP
- Japan
- Prior art keywords
- iron chelator
- human
- inflammation
- iron
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62960604P | 2004-11-19 | 2004-11-19 | |
| PCT/US2005/040898 WO2006055412A1 (en) | 2004-11-19 | 2005-11-10 | Methods of treating erythropoietin-resistance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008520669A JP2008520669A (ja) | 2008-06-19 |
| JP2008520669A5 true JP2008520669A5 (https=) | 2008-12-25 |
Family
ID=35809986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543135A Pending JP2008520669A (ja) | 2004-11-19 | 2005-11-10 | エリスロポエチン抵抗性を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060128805A1 (https=) |
| EP (1) | EP1819334A1 (https=) |
| JP (1) | JP2008520669A (https=) |
| AU (1) | AU2005306772A1 (https=) |
| CA (1) | CA2587558A1 (https=) |
| WO (1) | WO2006055412A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083966A (en) | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
| WO2005034949A1 (en) | 2003-09-09 | 2005-04-21 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| BRPI0610644B8 (pt) | 2005-04-04 | 2021-05-25 | Univ Florida | composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável. |
| CA2607953A1 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| BRPI0715123A2 (pt) * | 2006-08-04 | 2013-06-04 | Novartis Ag | tratamento de disfunÇço endàcrina usando quelantes de ferro |
| EP2101761A4 (en) * | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
| US20080132465A1 (en) * | 2006-12-05 | 2008-06-05 | Vincent Windisch | Apparatus and method for isolating iron components from serum |
| US20100137346A1 (en) * | 2006-12-12 | 2010-06-03 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogue actinide decorporation agents |
| JP5439193B2 (ja) | 2007-03-15 | 2014-03-12 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | デスフェリチオシンポリエーテル類似体 |
| JPWO2010032489A1 (ja) | 2008-09-22 | 2012-02-09 | 国立大学法人旭川医科大学 | 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法 |
| WO2010045589A2 (en) * | 2008-10-17 | 2010-04-22 | The General Hospital Corporation | Optimizing erythropoietin therapy |
| KR101735125B1 (ko) * | 2008-11-12 | 2017-05-15 | 리젠메드 (케이만) 엘티디. | 분리된 신장 세포 및 이의 용도 |
| WO2011143292A1 (en) * | 2010-05-11 | 2011-11-17 | Ohio University | Biomarkers for detecting erythropoietin use in human subjects |
| AU2011299153B2 (en) | 2010-09-10 | 2014-10-30 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for concomitant treatment of theophylline and febuxostat |
| WO2012096183A1 (ja) | 2011-01-14 | 2012-07-19 | 株式会社ダステック | 高分子鉄キレート剤 |
| SG193494A1 (en) | 2011-03-21 | 2013-10-30 | Vivolux Ab | Treatment of solid tumours |
| JP6539046B2 (ja) | 2011-12-16 | 2019-07-03 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | ４’−デスフェリチオシン類似体の使用 |
| WO2014046589A1 (en) | 2012-09-21 | 2014-03-27 | Vivolux Ab | Means and method for treating solid tumours |
| CA2930966A1 (en) | 2013-11-22 | 2015-05-28 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
| JP6725515B2 (ja) | 2015-01-09 | 2020-07-22 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | 小分子を用いた鉄欠乏生物における生理機能の回復 |
| EP3288557A4 (en) | 2015-04-27 | 2018-11-07 | University of Florida Research Foundation, Inc. | Metabolically programmed metal chelators and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8528983D0 (en) * | 1985-11-25 | 1986-01-02 | Ciba Geigy Ag | Use of chelating agents |
-
2005
- 2005-11-10 WO PCT/US2005/040898 patent/WO2006055412A1/en not_active Ceased
- 2005-11-10 CA CA002587558A patent/CA2587558A1/en not_active Abandoned
- 2005-11-10 EP EP05825725A patent/EP1819334A1/en not_active Withdrawn
- 2005-11-10 AU AU2005306772A patent/AU2005306772A1/en not_active Abandoned
- 2005-11-10 JP JP2007543135A patent/JP2008520669A/ja active Pending
- 2005-11-10 US US11/271,497 patent/US20060128805A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008520669A5 (https=) | ||
| CN104869993B (zh) | 治疗阿尔茨海默病及相关疾病的组合疗法 | |
| Afshar et al. | Effects of intradialytic aerobic training on sleep quality in hemodialysis patients | |
| Herbertson et al. | Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. | |
| JP2010540657A5 (https=) | ||
| JP2016513640A5 (https=) | ||
| Li et al. | Improved dialysis removal of protein-bound uremic toxins by salvianolic acids | |
| DE60030844D1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| JP2009526754A5 (https=) | ||
| EP2211913A4 (en) | SYSTEMIC ADMINISTRATION OF CHLOROTOXIN AGENTS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS | |
| WO2007006858A3 (en) | Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same | |
| HRP20141194T1 (hr) | Postupci lijeäśenja gihta | |
| JP2018531929A (ja) | Ｌ−オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも１つと組み合わせて用いる神経細胞喪失の治療および予防 | |
| JP2004517824A5 (https=) | ||
| KR102205368B1 (ko) | Fxr 작용제의 신규 요법 | |
| Buchwald et al. | Bariatric surgery. A systematic review and meta-analysis | |
| Kim et al. | Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats | |
| WO2001062799A3 (en) | Method for inhibiting angiogenesis using molecules that enhance plasmin activity | |
| JP2007119497A5 (https=) | ||
| Zhou et al. | Remote ischemic preconditioning ameliorates renal fibrosis after ischemia-reperfusion injury via transforming growth factor beta1 (TGF-β1) signalling pathway in rats | |
| CY1112440T1 (el) | Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3 | |
| JP2011500650A5 (https=) | ||
| Lee et al. | Long-term enteral arginine supplementation in rats with intestinal ischemia and reperfusion | |
| JP2004521140A5 (https=) | ||
| Liu et al. | Maraviroc‐Mediated Lung Protection following Trauma‐Hemorrhagic Shock |